Ozempic Is About to Go Generic in India, China and Canada

Health Consultant March 19, 2026 0

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.

from NYT > Health https://ift.tt/B25vaUK
via IFTTT

No comments

Subscribe to: Post Comments ( Atom )